Search clinical trials for: Immunotherapy, anti-CD38 antibody

Total 99423 results

University of Oxford
National Institute for Health Research, United Kingdom; 180 Life Sciences

Completed

The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study" (Anti-FreazeF)

Frozen Shoulder

United Kingdom
Sorrento Therapeutics, Inc.

Recruiting

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

Light Chain (AL) Amyloidosis

United States
Istituto Giannina Gaslini

Recruiting

Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome

Nephrotic Syndrome

Italy
Farsad Eskandary
Charite University, Berlin, Germany; University of Alberta; HI-Bio

Completed

Felzartamab in Late Antibody-Mediated Rejection

Antibody-mediated Rejection

Austria, Germany
JLLC NatiVita
National Anti Doping Laboratory, Belarus

Not yet recruiting

The Bioequivalence Study of Two Sunitinib Products in Capsules 50 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Belarus
Pharmtechnology LLC
National Anti-Doping Labaratory

Completed

Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Belarus
City of Hope Medical Center

Completed

Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma

Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Secondary Amyloidosis

United States
Sorrento Therapeutics, Inc.

Withdrawn

An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amyloidosis

Light Chain (AL) Amyloidosis
Institut de Recherche pour le Developpement

Completed

Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal

Tuberculosis

Senegal
Fate Therapeutics

Terminated

FT538 in Subjects With Advanced Hematologic Malignancies

Acute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, Adult

United States
Texas Tech University

Completed

Adherence to Walking on an Alter G Anti-Gravity Treadmill

Severe Obesity

United States
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies

AML

China
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders (THERAMAG)

Anti-MAG Neuropathy

France
Assiut University

Unknown

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Immune Thrombocytopenia
University Hospital, Montpellier

Completed

Impact of Immune Checkpoint Inhibitor Therapy on Type 2 Inflammation (ImmunEO)

Patients Recieving Anti-PD-1 or Anti-PD-L1 Immunotherapies

France
Anhui Provincial Hospital

Not yet recruiting

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

High Titers of Anti-HLA Antibody (MFI ≥5000)

China
Cynosure, Inc.

Completed

Evaluating the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles

Wrinkles

United States
Zhejiang ACEA Pharmaceutical Co. Ltd.

Recruiting

Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Centre Hospitalier Universitaire de Nīmes

Completed

Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home (PEDIAOBST)

Pediatric Population | Anti Infective

France
Y-mAbs Therapeutics

Not yet recruiting

Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Non-hodgkin Lymphoma

United States
Shenzhen Geno-Immune Medical Institute

Recruiting

CAR-T Immunotherapy Targeting CD19- ALL

B-cell Leukemia

China
Chinese PLA General Hospital

Unknown

A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy

Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI

China
University of Georgia

Recruiting

Neuroimaging Approaches to Improve Prediction of Smoking Initiation and Nicotine Use Escalation Among Young Adult Electronic Nicotine Delivery Systems Users

Message Exposure (Sequence: Regular Then Flavor) | Message Exposure (Sequence: Flavor Then Regular) | No Message Exposure (Control Condition)

United States
National Institute of Environmental Health Sciences...

Completed

A Cohort Study of Smoking Prevention and Health Promotion for Middle School Students in Wuhan, China

Asthma

China
University Hospital, Bordeaux

Completed

Causality of Poisoning of the Elderly: Prospective Study Based on Data From the Poison Control Centre of Bordeaux (GERIATOX)

Intoxication

France
University Hospital Dubrava

Completed

The Anti-inflammatory Effect of Anesthetics in Abdominal Surgery

Colorectal Cancer

Croatia
Tetraphase Pharmaceuticals, Inc.
Department of Health and Human Services

Completed

Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women (BAL)

Normal Drug Tolerance

United States
Georgetown University
Bristol-Myers Squibb; Targovax ASA; Janssen, LP

Recruiting

Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer (DARANIVOVAX)

Pancreatic Ductal Adenocarcinoma | Refractory Non-Small Cell Lung Cancer

United States
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.

Lymphoma | Hematological Malignancy

United States
Kamada, Ltd.

Completed

Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19

Pneumonia, Viral | Covid19

Israel
Jennifer Woyach

Active, not recruiting

Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
HI-Bio

Completed

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (IGNAZ)

Immunoglobulin A (IgA) Nephropathy

United Kingdom, Germany, Spain, Serbia, Taiwan, Australia, Japan, Korea, Republic of, Belgium, United States, Bulgaria, Czechia, Georgia, Malaysia, Philippines, Ukraine
EuroPharma, Inc.
Botalys SA

Completed

Ginseng HRG80 in Stress and Fatigue

Psychological Stress

Armenia
Peking University Third Hospital

Recruiting

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Proliferative Diabetic Retinopathy

China
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions

Anthelmintic Agent

Jordan
Pierre Fabre Dermo Cosmetique

Completed

Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream

Anti-aging

France
Assistance Publique - Hôpitaux de Paris

Completed

Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn (RAGIIF)

Anti-integrases

France
University Hospital, Bordeaux

Completed

Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy (CANNEMUSS)

COVID-19 | Neuromuscular Diseases | Amyotrophy

France
Emory University
National Cancer Institute (NCI)

Completed

FACBC Outcomes for Post Prostatectomy

Prostate Cancer

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Assessment of the Impact of Probiotics on Biofilm Formation on Removable Acrylic Dentures

Mandibular Prosthesis User

Belgium
Daniela Matei, MD
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Completed

Pembro/Carbo/Taxol in Endometrial Cancer

Endometrial Cancer | Endometrial Adenocarcinoma

United States
Assistance Publique - Hôpitaux de Paris
Etablissement Français du Sang (Nouvelle Aquitaine)

Recruiting

Obstetrical History and Anti-HLA Antibodies Level (OBS-HLA)

Blood Donors | Anti-HLA Antibody

France
The First Affiliated Hospital of Soochow University

Recruiting

CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Isfahan University of Medical Sciences

Recruiting

Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

Anti Aging

Iran, Islamic Republic of
Cosmetique Active International

Completed

Anti-aging Repairing Serum: Efficacy and Tolerability Study

Anti-aging

Brazil
920th Hospital of Joint Logistics Support Force...
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML

Acute Myeloid Leukemia

China
Northwestern University

Completed

Consumer Knowledge, Attitude, and Behavior Towards Aging Skin

Dermatology

United States
Chinese PLA General Hospital

Unknown

A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

China
Revision Skincare

Completed

A Twelve Week Clinical Study to Evaluate the Efficacy and Tolerability of a Sunscreen Moisturizer SPF 50+

Photoaging | Anti-aging

United States
RenJi Hospital

Completed

Antihypertensives in Non-cardiac Surgical Population

Perioperative Antihypertensive

China

Search clinical trials for: Immunotherapy, anti-CD38 antibody

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations